Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Kymera Therapeutics, Inc. (KYMR)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 62,339,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Kymera Therapeutics is a biopharmaceutical company focused on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. Co.'s proprietary targeted protein degradation platform, which Co. refers to as Pegasus™, allows Co. to discover selective small molecule protein degraders with activity against disease-causing proteins throughout the body. Co. has utilized its Pegasus™ platform to design protein degraders focused in the areas of immunology-inflammation and oncology, and Co. continues to apply its platform's capabilities to additional therapeutic areas.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 414,105 1,300,163
Total Buy Value $0 $0 $5,301,325 $25,027,880
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 2 8
Total Shares Sold 846,935 906,367 906,367 2,944,621
Total Sell Value $35,475,904 $37,488,861 $37,488,861 $99,885,268
Total People Sold 5 6 6 7
Total Sell Transactions 16 19 19 49
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 204
  Page 7 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-05-12 4 OE $2.08 $17,150 D/D 8,245 405,444     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-04-26 4 AS $40.18 $111,229 D/D (2,768) 397,199     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-04-26 4 OE $2.08 $5,757 D/D 2,768 399,967     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-04-23 4 AS $40.01 $27,208 D/D (680) 397,199     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-04-23 4 OE $2.08 $1,414 D/D 680 397,879     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-04-22 4 AS $40.26 $441,182 D/D (10,959) 397,199     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-04-22 4 OE $2.08 $22,795 D/D 10,959 408,158     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-04-19 4 OE $2.08 $13,838 D/D 6,653 397,199     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-04-19 4 AS $40.00 $26,121 D/D (653) 391,199     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-04-15 4 AS $40.29 $199,039 D/D (4,940) 391,199     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-04-15 4 OE $2.08 $10,275 D/D 4,940 396,139     -
   Jacobs Bruce N. Chief Financial Officer   •       –      –    2021-04-13 4 OE $2.08 $14,560 D/D 7,000 7,000     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-04-13 4 OE $2.08 $31,200 D/D 15,000 391,199     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-04-12 4 AS $32.29 $497,981 D/D (15,267) 376,199     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-04-12 4 OE $2.08 $31,755 D/D 15,267 391,466     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-04-09 4 AS $33.58 $767,750 D/D (22,794) 376,199     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-04-09 4 OE $2.08 $47,412 D/D 22,794 398,993     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-04-08 4 AS $34.81 $347,832 D/D (9,939) 376,199     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-04-08 4 OE $2.08 $20,673 D/D 9,939 386,138     -
   Jacobs Bruce N. Chief Financial Officer   •       –      –    2021-03-15 4 AS $60.17 $493,096 D/D (8,195) 0     -
   Jacobs Bruce N. Chief Financial Officer   •       –      –    2021-03-15 4 OE $2.08 $17,046 D/D 8,195 8,195     -
   Gollob Jared Chief Medical Officer   •       –      –    2021-03-15 4 AS $60.17 $620,052 D/D (10,305) 42,547     -
   Gollob Jared Chief Medical Officer   •       –      –    2021-03-15 4 OE $1.31 $10,218 D/D 7,800 52,852     -
   Booth Bruce Director   –       •      –    2021-03-12 4 S $56.50 $12,958,275 I/I (229,350) 0     -
   Atlas Venture Associates X, Llc 10% Owner   –       –       •   2021-03-12 4 S $56.50 $12,958,275 D/D (229,350) 0     -
  204 Records found
  1  2  3  4  5  6  7  8  9   
  Page 7 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us